Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-090432
Filing Date
2025-06-26
Accepted
2025-06-26 16:30:04
Documents
4
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 6-K ccls_6-k_agm_vote_result.htm 6-K 39892
2 EX-99.1 clls-ex99_1.htm EX-99.1 308891
3 EX-99.2 clls-ex99_2.htm EX-99.2 18686
4 GRAPHIC img135916342_0.jpg GRAPHIC 89766
  Complete submission text file 0000950170-25-090432.txt   492274
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36891 | Film No.: 251080798
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)